Sign in
Sign in
home page > News > Company news
Biomedical Project Speech
edit:SV 1898time:01/30/2019

19:00 - 19:45

APPLAUD

Stron IP position: 3 patents issued; 5+ patents pending

Clinical stage:42 total patients treated in early clinical studies for two products with indications in urology

Favorable regulatory paths: Classified as llb Device in EU Guidance from FDA for 510K de Novo device classification process


19:50 - 20:35

CAR-T for Solid Tumors

Antibody Assembly line

MabArrayTM

Cancer / Immune Surface Target Atlas